BRAF c.575C>A ;(p.P192Q)

Variant ID: 7-140508725-G-T

NM_004333.4(BRAF):c.575C>A;(p.P192Q)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Metastatic Melanoma Patient-Derived Xenografts Respond to MDM2 Inhibition as a Single Agent or in Combination with BRAF/MEK Inhibition.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Shattuck-Brandt, Rebecca L RL; Chen, Sheau-Chiann SC; Murray, Emily E; Johnson, Christopher Andrew CA; Crandall, Holly H; O'Neal, Jamye F JF; Al-Rohil, Rami Nayef RN; Nebhan, Caroline A CA; Bharti, Vijaya V; Dahlman, Kimberly B KB; Ayers, Gregory D GD; Yan, Chi C; Kelley, Mark C MC; Kauffmann, Rondi M RM; Hooks, Mary M; Grau, Ana A; Johnson, Douglas B DB; Vilgelm, Anna E AE; Richmond, Ann A
Publication Date: 2020-07-15

Variant appearance in text: BRAF: P192Q
PubMed Link: 32234759
Variant Present in the following documents:
  • Main text
View BVdb publication page



Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates.

Nature Communications
Kis, Olena O; Kaedbey, Rayan R; Chow, Signy S; Danesh, Arnavaz A; Dowar, Mark M; Li, Tiantian T; Li, Zhihua Z; Liu, Jessica J; Mansour, Mark M; Masih-Khan, Esther E; Zhang, Tong T; Bratman, Scott V SV; Oza, Amit M AM; Kamel-Reid, Suzanne S; Trudel, Suzanne S; Pugh, Trevor J TJ
Publication Date: 2017-05-11

Variant appearance in text: BRAF: 575C>A
PubMed Link: 28492226
Variant Present in the following documents:
  • ncomms15086-s3.xlsx, sheet 1
View BVdb publication page